Author(s): Ahmed Kareem Hussein Mubarak

Email(s): ahmed.mubar@uokufa.edu.iq

DOI: 10.5958/0974-360X.2018.00211.1   

Address: Ahmed Kareem Hussein Mubarak
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Kufa, Najaf, Iraq.
*Corresponding Author

Published In:   Volume - 11,      Issue - 3,     Year - 2018


ABSTRACT:
Anti metabolite cytarabine is fantastic molecule posses both of most important therapeutic action anti neoplastic and anti viralagent. Today the both of anti cancer and anti viral agent sharing the same therapeutic problems which limit their therapeutic pharmacological biological action which are (the resistance and the cytotoxicity and poor pharmacokinetics parameters). In our project we do the pharmaceutical chemical modifications on the cytarabine as nucleus and targeting amino functionality to design and synthesis the number of new derivatives in light of an pharmaceutical amino group prodrug modification strategies an imine formation to improve therapeutic action (antineoplastic and antiviral action), expected to explore new biological actionand to minimized the emergent resistance, cytotoxicity and expected to improve kinetics of cytarabine.


Cite this article:
Ahmed Kareem Hussein Mubarak. Design and Synthesis of Cytarabine new Derivatives as a Possible an Imine Prod rugs with Potential to improve Therapeutic Criteria. Research J. Pharm. and Tech. 2018; 11(3): 1131-1136. doi: 10.5958/0974-360X.2018.00211.1

Cite(Electronic):
Ahmed Kareem Hussein Mubarak. Design and Synthesis of Cytarabine new Derivatives as a Possible an Imine Prod rugs with Potential to improve Therapeutic Criteria. Research J. Pharm. and Tech. 2018; 11(3): 1131-1136. doi: 10.5958/0974-360X.2018.00211.1   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2018-11-3-58


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available